156 related articles for article (PubMed ID: 11850736)
1. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.
Giuliano F; Allard J
Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system agents in the treatment of erectile dysfunction.
Kendirci M; Walls MM; Hellstrom WJ
Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
[TBL] [Abstract][Full Text] [Related]
3. Centrally acting mechanisms for the treatment of male sexual dysfunction.
Miner MM; Seftel AD
Urol Clin North Am; 2007 Nov; 34(4):483-96, v. PubMed ID: 17983889
[TBL] [Abstract][Full Text] [Related]
4. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.
Hsieh GC; Hollingsworth PR; Martino B; Chang R; Terranova MA; O'Neill AB; Lynch JJ; Moreland RB; Donnelly-Roberts DL; Kolasa T; Mikusa JP; McVey JM; Marsh KC; Sullivan JP; Brioni JD
J Pharmacol Exp Ther; 2004 Jan; 308(1):330-8. PubMed ID: 14569075
[TBL] [Abstract][Full Text] [Related]
5. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and safety of apomorphine SL (Ixense (TM) ).
Montorsi F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
[TBL] [Abstract][Full Text] [Related]
7. Peripheral modulation of dopaminergic receptors affects erectile responses in rats.
El-Din MM; Senbel AM; Daabees TT; Sharabi FM
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):225-32. PubMed ID: 17371526
[TBL] [Abstract][Full Text] [Related]
8. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
[TBL] [Abstract][Full Text] [Related]
9. Oral treatment of erectile dysfunction with apomorphine SL.
Altwein JE; Keuler FU
Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction.
Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Zanoni M; Heaton JP; Rigatti P; Fazio F
Int J Impot Res; 2003 Jun; 15(3):203-9. PubMed ID: 12904807
[TBL] [Abstract][Full Text] [Related]
11. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
12. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
Heaton JP
Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of apomorphine SL (Uprima).
Bukofzer S; Livesey N
Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
[TBL] [Abstract][Full Text] [Related]
14. Central control of penile erection.
McKenna KE
Int J Impot Res; 1998 May; 10 Suppl 1():S25-34. PubMed ID: 9669218
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
[TBL] [Abstract][Full Text] [Related]
16. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
17. Apomorphine to Uprima: the development of a practical erectogenic drug: a personal perspective.
Morales A
Int J Impot Res; 2001 Aug; 13 Suppl 3():S29-34. PubMed ID: 11477489
[TBL] [Abstract][Full Text] [Related]
18. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).
Montorsi F; Padma-Nathan H; Glina S
Urology; 2006 Sep; 68(3 Suppl):26-37. PubMed ID: 17011373
[TBL] [Abstract][Full Text] [Related]
19. Pro-erectile effect of systemic apomorphine: existence of a spinal site of action.
Giuliano F; Allard J; Rampin O; Droupy S; Benoit G; Alexandre L; Bernabé J
J Urol; 2002 Jan; 167(1):402-6. PubMed ID: 11743364
[TBL] [Abstract][Full Text] [Related]
20. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
